Management Science and Innovation
Life Sciences
Contract Design for R&D Licensing
How should innovators design licensing contracts, when there is incomplete information on the partner’s valuation of the innovation, and limited control over the partner’s development efforts? (published in Operations Research)
R&D Project Valuation and Negotiations
How can we value early-stage R&D projects and support licensing negotiations? (published in Interfaces; recipient of INFORMS Case Competition Award)
Comparative Study of Dysphagia Research
When patients have successful outcomes post cancer treatment or CVA they then often have an uphill struggle to relearn new techniques for swallowing. This current study considers the current research and the implications for future research.
Predictive Analytics to Improve Patient Care
Small changes in nursing care can vastly improve survival rates in long-term patients and yet according to research published in the Journal Dysphagia these are not being followed. A modelling approach representing the ...more
Dark Pools a Benefit to All?
There are increasingly sophisticated algorithms being developed in the financial markets to seek out liquidity and yet not alert other parties. Do they benefit all stakeholders and can these algorithms also be adapted for early cancer diagnosis?
A Strategy for Corporate Project ‘buy-in’
Making use of the latest advances in the understanding of neuroscience can help make us better leaders and project managers. (Proceedings Projekte & Emotional Intelligenz conference Vienna also Principles of Project Management series, APM)
Outsourcing Decisions in Pharmaceutical and Biotechnology Firms
What are the key tradeoffs in outsourcing and
contract-manufacturing decisions in pharmaceutical and biotechnology firms?
Which operational and organisational capabilities ...More
Project Leader: Bilal Gokpinar
Exploring the Creative Process in Healthcare Policy Teams
This project explores the creative processes that occur
naturally in interdisciplinary teams developing healthcare IT policy. How does
engagement with different types of processes influence the generation and ....more.
Universities as engines for industrial growth
How has the rise of new science-based industries altered the organization of universities? A study of the development of university-industry relationships in Silicon Valley details the critical role of universities in the region’s success and outlines distinctive ...more.
Assessing the performance of Silicon Valley spin-off firms
Study on Silicon Valley firms and the academic laboratories these firms were spun off from. Findings highlight a significant impact of various organizational features of “founding laboratories” on the performance of firms in...more.
Universities’ relationship to the economy and public policy
Which
levers do policy makers in different countries have at their disposal in
fostering the development of science-based industries? How are they constrained
by existing labor- and financial- market institutions? (two book chapters).
Enhancing R&D productivity through academic collaborations
The study’s database comprises detailed information on activities in the academic community of 4,780 American and British science-based firms and the impact of these activities on R&D productivity. Findings outline strategic ...more.
Managing science-led innovation in high-tech firms
Which organizational levers do managers have at their disposal in organizing science-led R&D? Case studies highlight formal structures, routines, and cultures that distinguish successful science-based ventures (International workshop planned at ...more.
Commercializing disruptive technologies: Venture creation and the choice of business model
Commercializing disruptive technologies: Business models for a rough financial
climate More.
Manufacturing decisions and the commercialization of disruptive technologies
Manufacturing
expertise is often in short supply in novel industries. What are the implications
for business development? (Funded through TSB Regenerative Medicine
program).
Marketing disruptive technologies
What are
the challenges managers face in marketing disruptive technologies and how do
they alter the behavior of critical stakeholders? (with Research Associate Dr
Enrico Forti and funded through
Regenerative Medicine program).
Treating poor prognosis patients leads to higher learning rates in fertility care
Difficult undertakings offer valuable opportunities for
learning because knowledge and practices developed as a consequence of dealing
with difficult cases spill over and have ...more.
Managing creativity by design: Coordinating creative inputs in comic strip production
Can task design stand as a recipe for creativity? Or is it
that due process and accountability doesn’t agree with designer stubble and
artistic panache? This study investigates the ...more
Sweetening the Pill of Change? Marketing Radical Innovations in the Regenerative Medicine Industry
How are markets created? How to commercialize radical innovations? How to communicate pros and cons to prospect clients? This study leverages product-level data about the ...more
General Management
Richard’s work
‘Introduction to Management’ is now in its fourth edition; and a re-worked
version is to be published in the Autumn of 2011 (published by Palgrave
Macmillan).
Investment Appraisal: a managerial approach
An evaluation of the full context in which investment decisions
are made, and results produced (published by Macmillan)
Contemporary Strategic Management
A crystallisation of much of the work carried out over the previous ten years, and a definition of one aspect of management in practice (published by Palgrave Macmillan).
Performance and performance management
A crystallisation, analysis and evaluation of the strengths
and shortcomings of how managers and organisations assess and evaluate their
own performance for success and otherwise (published by Pearson).
Warfarin Dose Adjustment for Prevention of Stroke
Patients in risk of stroke are often prescribed anti-coagulant drugs to reduce the likelihood of formation of blood clots, potentially leading to a stroke event. Warfarin is the most widely prescribed anti-coagulant drug worldwide. Yet, warfarin is associated with a complex ...more
